JP2021512852A5 - - Google Patents

Info

Publication number
JP2021512852A5
JP2021512852A5 JP2020538791A JP2020538791A JP2021512852A5 JP 2021512852 A5 JP2021512852 A5 JP 2021512852A5 JP 2020538791 A JP2020538791 A JP 2020538791A JP 2020538791 A JP2020538791 A JP 2020538791A JP 2021512852 A5 JP2021512852 A5 JP 2021512852A5
Authority
JP
Japan
Prior art keywords
article
coating according
compound
coating
steroids
Prior art date
Application number
JP2020538791A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019148293A5 (https=
JP2021512852A (ja
JP7502186B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2019/050135 external-priority patent/WO2019148293A1/en
Publication of JP2021512852A publication Critical patent/JP2021512852A/ja
Publication of JP2021512852A5 publication Critical patent/JP2021512852A5/ja
Publication of JPWO2019148293A5 publication Critical patent/JPWO2019148293A5/ja
Application granted granted Critical
Publication of JP7502186B2 publication Critical patent/JP7502186B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020538791A 2018-02-02 2019-02-01 ステロイド二量体を含むガラス製剤およびその使用 Active JP7502186B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862625460P 2018-02-02 2018-02-02
US62/625,460 2018-02-02
US201862627608P 2018-02-07 2018-02-07
US62/627,608 2018-02-07
US201862758234P 2018-11-09 2018-11-09
US62/758,234 2018-11-09
PCT/CA2019/050135 WO2019148293A1 (en) 2018-02-02 2019-02-01 Glass formulations comprising steroid dimers and uses thereof

Publications (4)

Publication Number Publication Date
JP2021512852A JP2021512852A (ja) 2021-05-20
JP2021512852A5 true JP2021512852A5 (https=) 2022-01-31
JPWO2019148293A5 JPWO2019148293A5 (https=) 2022-01-31
JP7502186B2 JP7502186B2 (ja) 2024-06-18

Family

ID=67479137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020538791A Active JP7502186B2 (ja) 2018-02-02 2019-02-01 ステロイド二量体を含むガラス製剤およびその使用

Country Status (9)

Country Link
US (9) US11612567B2 (https=)
EP (1) EP3740494A4 (https=)
JP (1) JP7502186B2 (https=)
KR (1) KR102952719B1 (https=)
CN (1) CN111971292B (https=)
AU (1) AU2019214347B2 (https=)
CA (1) CA3087898A1 (https=)
MX (1) MX2020008017A (https=)
WO (3) WO2019148291A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111971292B (zh) 2018-02-02 2024-12-13 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
CN114599406A (zh) * 2019-07-10 2022-06-07 波纹疗法公司 包含二聚类固醇前药的表面涂层和可植入装置及其用途
JP2022541341A (ja) * 2019-07-25 2022-09-22 リップル セラピューティクス コーポレーション ステロイド二量体を含む物品と治療剤の送達におけるそれらの使用
WO2021024041A1 (en) 2019-08-07 2021-02-11 Ripple Therapeutics Corporation Controlled release drug dimers
CN111485325A (zh) * 2020-04-16 2020-08-04 青岛科技大学 一种耐高温的抗菌纳米纤维无纺布及其制备方法和用途
MX2022013665A (es) 2020-05-01 2022-11-30 Ripple Therapeutics Corp Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.
EP4108231A1 (en) 2021-06-25 2022-12-28 Johann-Wolfgang-Goethe-Universität Frankfurt am Main In-situ dissolving electrospun polymer fibers for ocular drug delivery
WO2023079362A1 (en) * 2021-11-03 2023-05-11 Ripple Therapeutics Corporation Processable compositions and use for the same
US20260007686A1 (en) * 2022-07-12 2026-01-08 Ripple Therapeutics Corporation Compositions and methods for improving vision
AU2024238803A1 (en) * 2023-03-23 2025-10-09 Praesidia Biotherapeutics Inc. Prodrugs, prodrug compositions and related methods
TR2024002978A1 (tr) * 2024-03-12 2025-09-22 İstanbul Tekni̇k Üni̇versi̇tesi̇ Elektroeği̇rme yöntemi̇yle elde edi̇len ve i̇laç yüklü bi̇yopoli̇mer nanoli̇flerle kaplanan göz i̇mplanti üreti̇m yöntemi̇

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1058886A (en) 1910-04-13 1913-04-15 Alfred Mueller Firing mechanism for firearms.
FR7604M (https=) 1968-04-22 1970-01-19
DE1768345B2 (de) * 1968-05-03 1976-12-02 Hoechst Ag, 6000 Frankfurt Dimere steroid-21-alkylcarbonate und verfahren zu ihrer herstellung
US4024871A (en) 1975-07-23 1977-05-24 Ethicon, Inc. Antimicrobial sutures
WO2001007657A1 (en) 1999-07-27 2001-02-01 Phylos, Inc. Peptide acceptor ligation methods
US4532316A (en) 1984-05-29 1985-07-30 W. L. Gore & Assoc., Inc. Phase separating polyurethane prepolymers and elastomers prepared by reacting a polyol having a molecular weight of 600-3500 and isocyanate and a low molecular weight chain extender in which the ratios of reactants have a limited range
PL257230A1 (en) 1985-12-31 1988-03-03 Zaklad Polimerow Pan Novel segmented polymer and method of obtaining them
IL88003A (en) 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US4916193A (en) 1987-12-17 1990-04-10 Allied-Signal Inc. Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
NZ240846A (en) * 1990-12-06 1994-04-27 Hoechst Ag Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
US5321099A (en) 1992-01-02 1994-06-14 The Dow Chemical Company Blends of semi-crystalline polyamides and polyesteramides
US5217493A (en) 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
TW289020B (https=) 1993-05-08 1996-10-21 Hoechst Sktiengesellschaft
IT1270836B (it) 1993-10-27 1997-05-13 Archimica Spa Procedimento per la preparazione di rufloxacina e suoi sali
PT740650E (pt) * 1994-01-28 2004-10-29 Univ Kentucky Res Found Co-farmacos como um metodo de administracao controlada de farmacos
US6051576A (en) 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5387598A (en) 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
PT755386E (pt) 1994-04-13 2002-11-29 Romark Lab Lc Derivado de benzamida composicoes contendo o referido derivado e sua utilizacao
US5965590A (en) 1994-09-08 1999-10-12 Romark Lab Lc Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A (en) 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
MX9604483A (es) 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
US5856348A (en) 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
DE19521642C2 (de) 1995-06-14 2000-11-09 Aesculap Ag & Co Kg Implantat, seine Verwendung in der Chirurgie und Verfahren zu seiner Herstellung
NZ313583A (en) 1995-08-03 1999-01-28 Paul J Santerre Fluoroligomer surface modifiers for polymers
DE69708461T2 (de) 1996-02-15 2002-06-27 Marc W. Mittelman Bioresponsive pharmakologisch aktive polymere und daraus hergestellte gegenstände
KR0176334B1 (ko) 1996-08-19 1999-04-01 박원훈 내인체 감염성 삽입금속표면의 코팅방법 및 그 치료기술
US5728751A (en) 1996-11-25 1998-03-17 Meadox Medicals, Inc. Bonding bio-active materials to substrate surfaces
ES2232687T3 (es) 1997-05-07 2005-06-01 Romark Laboratories, L.C. Composiciones farmaceuticas de tizoxanida y/o nitazoxanida.
NZ502358A (en) 1997-07-18 2002-11-26 Infimed Therapeutics Inc Hydrogel composition comprising a biologically active substance combined with a macromer
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
PT1032605E (pt) 1997-09-10 2007-12-12 Univ Rutgers Polianidridos com produtos de degradação terapeuticamente úteis
US6468519B1 (en) 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
WO1999055396A1 (en) 1998-04-27 1999-11-04 Surmodics, Inc. Bioactive agent release coating
CA2340652C (en) 1998-08-20 2013-09-24 Cook Incorporated Coated implantable medical device comprising paclitaxel
CA2771263A1 (en) 2000-07-27 2002-02-07 Rutgers, The State University Therapeutic polyesters and polyamides
US6602915B2 (en) 2000-07-27 2003-08-05 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
WO2002087586A1 (en) 2001-04-26 2002-11-07 Control Delivery Systems, Inc. Sustained release drug delivery system containing codrugs
CA2349989A1 (en) 2001-06-07 2002-12-07 Paul J. Santerre Bioactive surface modifiers for polymers and articles made therefrom
US9056048B2 (en) * 2001-08-16 2015-06-16 The Trustees Of The University Of Pennsylvania Synthesis and use of cationic steroids for anti-inflammatory drug therapy
US20030158598A1 (en) 2001-09-17 2003-08-21 Control Delivery Systems, Inc. System for sustained-release delivery of anti-inflammatory agents from a coated medical device
BR0212897A (pt) 2001-09-21 2004-08-24 Univ Tulane Conjugados de análogos de somatostatina ou bombesina diagnóstica ou terapêutica e usos dos mesmos
AUPR879601A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1448231A1 (en) * 2001-11-19 2004-08-25 Control Delivery Systems, Inc. Topical delivery of codrugs
US20050164994A1 (en) 2001-12-10 2005-07-28 Control Deliver Systems, Inc. Treatment of genitourinary tract disorders
CA2472188C (en) * 2002-01-18 2011-06-21 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
CA2493748A1 (en) 2002-08-14 2004-02-26 Medical College Of Georgia Research Institute, Inc. Methods and compositions for treatment of macular and retinal disease
TW200500067A (en) 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
WO2004112838A2 (en) 2003-05-21 2004-12-29 Control Delivery Systems, Inc. Codrugs of diclofenac
CA2553816A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
US20050220841A1 (en) 2004-04-06 2005-10-06 Dewitt David M Coating compositions for bioactive agents
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
CA2571320C (en) 2004-05-14 2016-05-10 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
WO2005110485A1 (en) 2004-05-14 2005-11-24 Interface Biologics Inc. Polymeric coupling agents and pharmaceutically-active polymers made therefrom
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
US8357385B2 (en) 2008-04-07 2013-01-22 Interface Biologics Inc. Combination therapy for the treatment of bacterial infections
US8461171B2 (en) 2010-02-09 2013-06-11 QRxPharma Ltd. Hybrid opioid compounds and compositions
WO2011120044A1 (en) 2010-03-26 2011-09-29 Duke University Conjugated neuroactive steroid compositions and methods of use
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
WO2013106528A1 (en) 2012-01-10 2013-07-18 Virginia Commonwealth University Bivalent ligands for the treatment of neurological disorders
WO2014138425A1 (en) 2013-03-08 2014-09-12 Allergan, Inc. Cyclosporine a-steroid conjugates
DK3357522T3 (da) 2013-03-15 2020-01-27 Ripple Therapeutics Corp Coatet medicinsk genstand til lægemiddelsfrigivelse
LT3137081T (lt) 2014-04-28 2018-02-26 Orphomed, Inc. Buprenorfino dimeras ir jo naudojimas gydant virškinamojo trakto sutrikimus
EP3374369B1 (en) * 2015-11-12 2020-03-18 Board of Regents of the University of Nebraska Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
CN111971292B (zh) 2018-02-02 2024-12-13 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
CN114599406A (zh) 2019-07-10 2022-06-07 波纹疗法公司 包含二聚类固醇前药的表面涂层和可植入装置及其用途
JP2022541341A (ja) 2019-07-25 2022-09-22 リップル セラピューティクス コーポレーション ステロイド二量体を含む物品と治療剤の送達におけるそれらの使用

Similar Documents

Publication Publication Date Title
JP2021512852A5 (https=)
CN101553235B (zh) 甾族化合物前药在治疗眼后段疾病中的用途
CN111971292B (zh) 包含类固醇二聚体的玻璃制剂及其用途
JPWO2019148293A5 (https=)
PL207955B1 (pl) 17α-Alkilo-17ß-oksy-estratrieny, ich zastosowanie oraz preparaty farmaceutyczne je zawierające
JP2002520287A (ja) 黄斑変性における血管新生の予防的治療
EP1755616A2 (en) Treatment of ophthalmic conditions with mineralcorticoids
JP2002539263A (ja) 徐放性副腎皮質ステロイドによる網膜症の治療方法または防止方法
WO2011009530A2 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9 (10)-dien-11-acyloxyalkylenphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
US20070238714A1 (en) Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
JP2022548464A (ja) 二量体ステロイドプロドラッグを含む表面コーティングおよび埋込み可能なデバイス、およびその使用
EP3139908A1 (en) Formulations and methods for vaginal delivery of antiprogestins
CN100431544C (zh) 用于治疗病理性眼血管生成的糖皮质激素制剂
CA2064478C (en) Ophthalmic composition
JP2013523748A5 (https=)
US20090029954A1 (en) Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
US20080261929A1 (en) Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseases
US20060094664A1 (en) Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
CA2620346A1 (en) Control of induced elevated intraocular pressure
WO2005102297A2 (en) Angiostatic agents for controlling choroidal neovascularisation after ocular surgery of trauma
CN101094690A (zh) 用于治疗眼后节的组合物及方法
WO2023079362A1 (en) Processable compositions and use for the same
JPWO2023154980A5 (https=)
WO2013133980A1 (en) Nitroxy derivatives of soft steroids
WO1999065498A1 (en) Agents for relieving side effects of adrenal cortex hormone